Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Single-dose primaquine added to artemether-lumefantrine for Plasmodium falciparum malaria
PACTR202502642820967Completed
- Sponsor
- University of Bergen
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of artemether + lumefantrine and primaquine in Malaria (2 arms), sponsored by University of Bergen. Primary endpoints: Parasitological response by microscopy and Gametocyte carriage by microscopy. Started Mar 2023; status: completed.
02
Drugs
artemether + lumefantrineprimaquine
03
Conditions
Malaria
Beyond the preview
Go deeper on PACTR202502642820967.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202502642820967.